3:31 AM
 | 
May 15, 2018
 |  BC Extra  |  Financial News

Third Rock leads $65M A round for Celsius

Celsius Therapeutics (Cambridge, Mass.) launched with a $65 million series A round led by Third Rock Ventures. Also participating were GV, Heritage Provider Network, Casdin Capital, Alexandria Venture Investments and undisclosed other investors.

Celsius aims to discover and...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >